These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25185888)

  • 1. Increase in the pharmacological management of Type 2 diabetes with pay-for-performance in primary care in the UK.
    Gallagher N; Cardwell C; Hughes C; O'Reilly D
    Diabet Med; 2015 Jan; 32(1):62-8. PubMed ID: 25185888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of payment incentives on cancer screening in Ontario primary care.
    Kiran T; Wilton AS; Moineddin R; Paszat L; Glazier RH
    Ann Fam Med; 2014 Jul; 12(4):317-23. PubMed ID: 25024239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of financial incentives on the quality of health care provided by primary care physicians.
    Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes.
    Heald A; Davies M; Stedman M; Livingston M; Lunt M; Fryer A; Gadsby R
    BMJ Open; 2019 Sep; 9(9):e028278. PubMed ID: 31494602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Pay-for-Performance for Primary Care Physicians on Preventable Diabetes-Related Hospitalization Costs Among Adults in New Brunswick, Canada: A Quasiexperimental Evaluation.
    Gupta N; Lavallée R; Ayles J
    Can J Diabetes; 2019 Jul; 43(5):354-360.e1. PubMed ID: 30679059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitals and GPs are offered incentives to reduce antibiotic prescribing.
    Wise J
    BMJ; 2016 Mar; 352():i1499. PubMed ID: 26977082
    [No Abstract]   [Full Text] [Related]  

  • 8. Pay for performance (P4P) in medical imaging: the time has (finally) come.
    Reiner BI; Siegel EL
    J Digit Imaging; 2006 Dec; 19(4):289-94. PubMed ID: 17136488
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes Study.
    Millett C; Gray J; Saxena S; Netuveli G; Khunti K; Majeed A
    PLoS Med; 2007 Jun; 4(6):e191. PubMed ID: 17564486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of a new incentive and target-based contract for family physicians in the UK: good for older patients with diabetes but less good for women?
    McGovern MP; Williams DJ; Hannaford PC; Taylor MW; Lefevre KE; Boroujerdi MA; Simpson CR
    Diabet Med; 2008 Sep; 25(9):1083-9. PubMed ID: 18937676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with quality prescribing indicators linked to financial incentives: what about not incentivized indicators?: an observational study.
    Fernández Urrusuno R; Pérez Pérez P; Montero Balosa MC; Márquez Calzada C; Pascual de la Pisa B
    Eur J Clin Pharmacol; 2014 Mar; 70(3):303-11. PubMed ID: 24297343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit.
    Heald AH; Livingston M; Fryer A; Moreno GYC; Malipatil N; Gadsby R; Ollier W; Lunt M; Stedman M; Young RJ
    Diabet Med; 2018 Jan; 35(1):63-71. PubMed ID: 29120503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pay for performance on the quality of primary care in England.
    Campbell SM; Reeves D; Kontopantelis E; Sibbald B; Roland M
    N Engl J Med; 2009 Jul; 361(4):368-78. PubMed ID: 19625717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008.
    Currie CJ; Peters JR; Evans M
    Diabet Med; 2010 Jul; 27(7):744-52. PubMed ID: 20636954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of financial incentives for case finding for depression in patients with diabetes and coronary heart disease: interrupted time series analysis.
    McLintock K; Russell AM; Alderson SL; West R; House A; Westerman K; Foy R
    BMJ Open; 2014 Aug; 4(8):e005178. PubMed ID: 25142262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*.
    Currie CJ; Gale EA; Poole CD
    Diabet Med; 2010 Aug; 27(8):938-48. PubMed ID: 20653753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction.
    Hadley J; Mitchell JM; Sulmasy DP; Bloche MG
    Health Serv Res; 1999 Apr; 34(1 Pt 2):307-21. PubMed ID: 10199677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of practice size and pay-for-performance incentives with the quality of diabetes management in primary care.
    Vamos EP; Pape UJ; Bottle A; Hamilton FL; Curcin V; Ng A; Molokhia M; Car J; Majeed A; Millett C
    CMAJ; 2011 Sep; 183(12):E809-16. PubMed ID: 21810950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands.
    van Avendonk MJ; Gorter KJ; van den Donk M; Rutten GE
    Prim Care Diabetes; 2009 Feb; 3(1):23-8. PubMed ID: 19095513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pay for performance in primary care in England and California: comparison of unintended consequences.
    McDonald R; Roland M
    Ann Fam Med; 2009; 7(2):121-7. PubMed ID: 19273866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.